Gandeeva Therapeutics

Gandeeva Therapeutics

Edit info

  • Founded: 2021
  • Location: Vancouver, BC
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: GND-01
  • Funding: $40M A Jan 2022


gandeeva.com

linkedin.com

job board


Drug notes:

GND-02 RD oncology; GND-03 RD oncology; GND-04 RD oncology

About:

Gandeeva Therapeutics is using the power of cryo-EM and machine learning to advance drug discovery. Cryo-EM is a microscopy method that enables visualization of protein structures. Protein structures and their interactions are altered in almost all diseases. Using advances in resolution of cryo-EM in their platform, Gandeeva is imaging protein interfaces and using machine learning to develop precision medicines to treat challenging diseases. The Cryo-EM engine, HYPERFOCUS, enables mapping of druggable sites onto atomic resolution protein images. Gandeeva’s approach will tackle many targets from allosteric proteins, protein-protein complexes, nucleic acid protein complexes to membrane proteins using therapies ranging from small molecules to engineered antibodies.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com